Medscape published a report on research by Ambria Moten, MD, MS, Surgery Resident at Temple University Hospital, and colleagues, that found that about a quarter of all patients with low-risk thyroid cancer are still receiving radioactive iodine (RAI) therapy despite recommendations against its use in the patient population. The research was published in the June issue of Surgical Oncology.
IMPORTANT: Beginning at 8:00 AM on September 3, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH